Printer Friendly

HEALTHWATCH INTRODUCES NEW VASCULAR TESTING EQUIPMENT - PAP II

 HEALTHWATCH INTRODUCES NEW VASCULAR TESTING EQUIPMENT - PAP II
 BROOMFIELD, Colo., March 27 /PRNewswire/ -- HealthWatch Inc. (NASDAQ: HEAL) today announced the release of its new Life Sciences Portable Air Plethysmograph II (PAP-II) for the physician office market. The PAP-II gives physicians the capability of doing blood flow analysis testing for vascular disease in their office. Vascular disease is the third leading cause of death in the U.S.
 "This is the first new product developed for our Life Sciences vascular division specifically for our new physician sales force," said President and Chief Operating Officer, Charles P. Spickert. "We are optimistic about this new product because it gives hospital quality vascular testing capabilities to the office-based physician at an economical price."
 Based in Broomfield, HealthWatch is a leading manufacturer of medical equipment for the purpose of diagnosing human cardiovascular disease. HealthWatch markets cardiology and vascular products under its Cambridge Medical and Life Sciences labels, respectively.
 -0- 3/27/92
 /CONTACT: Sanford L. Schwartz of HealthWatch, 303-465-2000/
 (HEAL) CO: HealthWatch Inc. ST: Colorado IN: HEA SU:


BB -- DV003 -- 2258 03/27/92 09:01 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 27, 1992
Words:182
Previous Article:COALITION FOR SAFE CERAMICWARE URGES CONGRESS AND FDA TO ENFORCE CURRENT LEAD STANDARDS -- NOT TO 'PUT POLITICS ABOVE SCIENCE'
Next Article:NIKE ACQUIRES MEXICAN DISTRIBUTION RIGHTS, EXTENDING MARKETING CONTROL OVER ALL ITS NORTH AMERICAN OPERATIONS
Topics:


Related Articles
HEALTHWATCH BUILDS PHYSICIAN OFFICE MARKET SALES FORCE
HEALTHWATCH ANNOUNCES NEW SPIROMETRY PRODUCT LINE
HEALTHWATCH INTRODUCES NEW LIFE SCIENCES MVL CLASSIC
HEALTHWATCH RECEIVES FDA APPROVAL TO MARKET NEW PC-BASED EXERCISE STRESS TESTING SYSTEM
HEALTHWATCH RECEIVES GOLD AESCULAPIUS AWARD IN POLAND
HEALTHWATCH ANNOUNCES NEW HOLTER MONITOR PRODUCT LINE
HEALTHWATCH ANNOUNCES PLANNED ACQUISITION OF METAMED INC.
HEALTHWATCH ANNOUNCES FUNDING AGREEMENT WITH THE ROCKIES FUND
Digene Introduces New HPV DNA Test At Eurogin 97 Third International Congress
New Pap Test Improves Early Cancer Detection

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters